Lynda Partridge Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB) University of Sheffield Biography Publications Institution JoVE Articles Lynda Partridge has not added a biography. If you are Lynda Partridge and would like to personalize this page please email our Author Liaison for assistance. Publications A Role for Tetraspanin Proteins in Regulating Fusion Induced by Burkholderia Thailandensis Medical Microbiology and Immunology. Apr, 2020 | Pubmed ID: 32253503 Characterization of Ocular Clinical Isolates of from Non-Contact Lens Related Keratitis Patients from South India Microorganisms. Feb, 2020 | Pubmed ID: 32075262 Monocyte Subsets Have Distinct Patterns of Tetraspanin Expression and Different Capacities to Form Multinucleate Giant Cells Frontiers in Immunology. 2018 | Pubmed ID: 29937768 The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations Toxins. 10, 2017 | Pubmed ID: 29076988 A Role for the Tetraspanin Proteins in Salmonella Infection of Human Macrophages The Journal of Infection. 08, 2017 | Pubmed ID: 28602860 Tspan2: a Tetraspanin Protein Involved in Oligodendrogenesis and Cancer Metastasis Biochemical Society Transactions. 04, 2017 | Pubmed ID: 28408487 Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes PloS One. 2016 | Pubmed ID: 27467693 Two Complementary Approaches for Intracellular Delivery of Exogenous Enzymes Scientific Reports. Jul, 2015 | Pubmed ID: 26207613 Distinct Regions of the Large Extracellular Domain of Tetraspanin CD9 Are Involved in the Control of Human Multinucleated Giant Cell Formation PloS One. 2014 | Pubmed ID: 25551757 Tetraspanins: Gateways for Infection Infectious Disorders Drug Targets. Feb, 2012 | Pubmed ID: 22034932 A Burkholderia Pseudomallei Toxin Inhibits Helicase Activity of Translation Factor EIF4A Science (New York, N.Y.). Nov, 2011 | Pubmed ID: 22076380 Regulation of Zebrafish Hatching by Tetraspanin Cd63 PloS One. 2011 | Pubmed ID: 21625559 Cooperative Role for Tetraspanins in Adhesin-mediated Attachment of Bacterial Species to Human Epithelial Cells Infection and Immunity. Jun, 2011 | Pubmed ID: 21464080 The Role of Tetraspanins in Fusion Biochemical Society Transactions. Apr, 2011 | Pubmed ID: 21428932 Strategies for Targeting Tetraspanin Proteins: Potential Therapeutic Applications in Microbial Infections BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 2009 | Pubmed ID: 19894777 Distinct Roles for Tetraspanins CD9, CD63 and CD81 in the Formation of Multinucleated Giant Cells Immunology. Jun, 2009 | Pubmed ID: 19489128 Characterisation of Receptor Binding by the Chemotaxis Inhibitory Protein of Staphylococcus Aureus and the Effects of the Host Immune Response Molecular Immunology. Apr, 2007 | Pubmed ID: 17258808 The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding The Journal of Biological Chemistry. Feb, 2007 | Pubmed ID: 17158873 Recombinant Extracellular Domains of Tetraspanin Proteins Are Potent Inhibitors of the Infection of Macrophages by Human Immunodeficiency Virus Type 1 Journal of Virology. Jul, 2006 | Pubmed ID: 16775336 Crystallization of a Carbamatase Catalytic Antibody Fab Fragment and Its Complex with a Transition-state Analogue Acta Crystallographica. Section D, Biological Crystallography. Jan, 2004 | Pubmed ID: 14684920 Structural Requirements for the Inhibitory Action of the CD9 Large Extracellular Domain in Sperm/oocyte Binding and Fusion Biochemical and Biophysical Research Communications. Nov, 2003 | Pubmed ID: 14575715 High-resolution Crystal Structure of the Fab-fragments of a Family of Mouse Catalytic Antibodies with Esterase Activity Journal of Molecular Biology. Sep, 2003 | Pubmed ID: 12948492 Direct Screening for Phosphatase Activity by Turnover-based Capture of Protein Catalysts Angewandte Chemie (International Ed. in English). Mar, 2002 | Pubmed ID: 12491332 Stabilire un modello di Cornea ex vivo suina per lo studio dei trattamenti farmacologici contro la cheratite batterica Katarzyna Okurowska1,2, Sanhita Roy3, Praveen Thokala4, Lynda Partridge1,5, Prashant Garg3, Sheila MacNeil1,6, Peter N. Monk1,7, Esther Karunakaran1,2 1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield, 2Department of Chemical and Biological Engineering, University of Sheffield, 3Hyderabad Eye Research Foundation, L V Prasad Eye Institute, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, 5Department of Molecular Biology and Biotechnology, University of Sheffield, 6Department of Materials Science and Engineering, University of Sheffield, 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield JoVE 61156 Immunologie et Infection
Stabilire un modello di Cornea ex vivo suina per lo studio dei trattamenti farmacologici contro la cheratite batterica Katarzyna Okurowska1,2, Sanhita Roy3, Praveen Thokala4, Lynda Partridge1,5, Prashant Garg3, Sheila MacNeil1,6, Peter N. Monk1,7, Esther Karunakaran1,2 1Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB), University of Sheffield, 2Department of Chemical and Biological Engineering, University of Sheffield, 3Hyderabad Eye Research Foundation, L V Prasad Eye Institute, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, 5Department of Molecular Biology and Biotechnology, University of Sheffield, 6Department of Materials Science and Engineering, University of Sheffield, 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield JoVE 61156 Immunologie et Infection